Clinical Neuroscience - 2008;61(07-08)

Content

Journal Special issues Previous issue Next number Archives

Clinical Neuroscience

JULY 30, 2008

[Evolution of human brain and intelligence]

LAKATOS László, JANKA Zoltán

[The biological evolution, including human evolution is mainly driven by environmental changes. Accidental genetic modifications and their innovative results make the successful adaptation possible. As we know the human evolution started 7-8 million years ago in the African savannah, where upright position and bipedalism were significantly advantageous. The main drive of improving manual actions and tool making could be to obtain more food. Our ancestor got more meat due to more successful... tovább »

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2008;61(07-08)

Clinical Neuroscience

JULY 30, 2008

[BRAIN LATERALIZATION AND SEIZURE SEMIOLOGY: ICTAL CLINICAL LATERALIZING SIGNS]

HORVÁTH A. Réka, KALMÁR Zsuzsanna, FEHÉR Nóra, FOGARASI András, GYIMESI Csilla, JANSZKY József

[Clinical lateralizing signs are the phenomena which can unequivocally refer to the hemispheric onset of epileptic seizures. They can improve the localization of epileptogenic zone during presurgical evaluation, moreover, their presence can predict a success of surgical treatment. Primary sensory phenomena such as visual aura in one half of the field of vision or unilateral ictal somatosensory sensation always appear on the contralateral to the focus. Periictal unilateral headache, although it... tovább »

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2008;61(07-08)

Clinical Neuroscience

JULY 30, 2008

[IMPORTANT AIM OF STATIN THERAPY: ISCHEMIC CARDIOVASCULAR EVENT (STROKE)]

CSÁSZÁR Albert

[Statin’s treatment clearly is authorized in prevention of coronary heart disease (CHD). According to the results of many studies and meta-analyses statins can inhibit the first cerebrovascular infarct (stroke). The greater the decrease of LDL-cholesterol level the more prominent the efficacy. The effect is not so robustic compared to coronaria vessels moreover clear pleiotropic (cholesterol independent) action takes also part. It has been nowadays revealed that high dose (80 mg) atorvastatin... tovább »

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2008;61(07-08)

Clinical Neuroscience

JULY 30, 2008

[SUCCESSFULL SURGICAL REMOVAL OF A MESENCEPHALIC CAVERNOUS ANGIOMA, WHICH WAS RESPONSIBLE FOR PROGRESSIVE NEUROLOGICAL DEFICITS]

ZSOLDOS Tamás, MOLNÁR Anna, JÁNOSSY Ágota, KUNCZ Ádám, NAGY Ernő, DEÁK Gábor, BARZÓ Pál

[Cavernous angiomas comprise 5-10% of all vascular malformations in the central nervous system, occuring most frequently in the supratentorial region, and 20% of them in the brain stem. According to literature, brain stem cavernous angiomas occur most frequently in the pons (60%), and equally in the mesencephalon (20%) and in medulla oblongata. In clinical evaluation the authors describe the successful removal of a mesencephalic cavernous angioma causing progressive neurological deficits and... tovább »

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2008;61(07-08)

Clinical Neuroscience

JULY 30, 2008

[IDIOPATHIC TOLOSA-HUNT SYNDROME: FOUR ADDITIONAL CASES]

D Kirbas, B Topcular, ME Ozcan, N Sakalli Karagoz, G Gul, I Aslan Kalyoncu

[Idiopathic Tolosa-Hunt syndrome (ITHS) is a very rare cause of painful ophthalmoplegia characterized by unilateral orbital pain, ipsilateral oculomotor paralysis and prompt response to steroids. In this paper we report 4 additional cases of ITHS. This rare cause of painful ophthalmoplegia effects the cranial nerves due to a granulomatous lesion of unknown etiology in the cavernous sinus or superior orbital fissure. The International Headache Society redefined the diagnostic criteria for ITHS... tovább »

PDF| ÖSSZEFOGLALÓ Cite COPYRIGHT FEES

HUN

2008;61(07-08)

Clinical Neuroscience

JULY 30, 2008